PG vs SPRO · P/E 25, rev $84.28B vs P/E 9.6, rev $48.0M
Procter & Gamble Company (PG) versus Spero Therapeutics Inc (SPRO) — a side-by-side from cached financials, not a winner call.
Procter & Gamble Company (PG) is a household & personal products company listed on US. It is led by Jon Moeller.
Spero Therapeutics Inc (SPRO) is a biotechnology company listed on NASDAQ.
Latest reported PG revenue for 2025-06-30 was $84.28B. Net income was $15.97B. PG currently screens at market cap $373.53B and trailing P/E 25.3.
Latest reported SPRO revenue for 2024-12-31 was $48.0M. Net income was -$68.6M. Revenue was down 53.8% from 2023-12-31 to 2024-12-31. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
PG currently screens at market cap $373.53B and trailing P/E 25.3. SPRO currently screens at market cap $149.5M and trailing P/E 9.6.
Not investment advice. Open the PG and SPRO stock pages for the full models.
Not investment advice.